Your browser doesn't support javascript.
loading
Phase I study of onapristone, a type I antiprogestin, in female patients with previously treated recurrent or metastatic progesterone receptor-expressing cancers.
Cottu, Paul H; Bonneterre, Jacques; Varga, Andrea; Campone, Mario; Leary, Alexandra; Floquet, Anne; Berton-Rigaud, Dominique; Sablin, Marie-Paule; Lesoin, Anne; Rezai, Keyvan; Lokiec, François M; Lhomme, Catherine; Bosq, Jacques; Bexon, Alice S; Gilles, Erard M; Proniuk, Stefan; Dieras, Veronique; Jackson, David M; Zukiwski, Alexander; Italiano, Antoine.
Afiliação
  • Cottu PH; Department of Medical Oncology, Institut Curie, Paris, France.
  • Bonneterre J; Department of Medical Oncology, Centre Oscar Lambret, Lille, France.
  • Varga A; Department of Medical Oncology, Gustave Roussy, Villejuif, France.
  • Campone M; Department of Medical Oncology, Institut de Cancérologie de l'Ouest-René Gauducheau, Nantes, France.
  • Leary A; Department of Medical Oncology, Gustave Roussy, Villejuif, France.
  • Floquet A; Department of Medical Oncology, Institut Bergonié, Bordeaux, France.
  • Berton-Rigaud D; Department of Medical Oncology, Institut de Cancérologie de l'Ouest-René Gauducheau, Nantes, France.
  • Sablin MP; Department of Medical Oncology, Institut Curie, Paris, France.
  • Lesoin A; Department of Medical Oncology, Centre Oscar Lambret, Lille, France.
  • Rezai K; Department of Medical Oncology, Centre Rene Huguenin-Institut Curie, St Cloud, France.
  • Lokiec FM; Department of Medical Oncology, Centre Rene Huguenin-Institut Curie, St Cloud, France.
  • Lhomme C; Department of Medical Oncology, Gustave Roussy, Villejuif, France.
  • Bosq J; Department of Medical Oncology, Gustave Roussy, Villejuif, France.
  • Bexon AS; Bexon Clinical Consulting, Upper Montclair, NJ, United States of America.
  • Gilles EM; Invivis Pharmaceuticals, Bridgewater, NJ, United States of America.
  • Proniuk S; Arno Therapeutics, Flemington, NJ, United States of America.
  • Dieras V; Department of Medical Oncology, Institut Curie, Paris, France.
  • Jackson DM; Arno Therapeutics, Flemington, NJ, United States of America.
  • Zukiwski A; Arno Therapeutics, Flemington, NJ, United States of America.
  • Italiano A; Department of Medical Oncology, Institut Bergonié, Bordeaux, France.
PLoS One ; 13(10): e0204973, 2018.
Article em En | MEDLINE | ID: mdl-30304013
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptores de Progesterona / Gonanos / Antineoplásicos Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptores de Progesterona / Gonanos / Antineoplásicos Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article